Raia Drogasil SA (RADLY)
4.90
-0.60
(-10.91%)
USD |
OTCM |
May 17, 16:00
Raia Drogasil Price to Book Value: 6.944 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 6.944 |
| May 16, 2024 | 7.795 |
| May 15, 2024 | 6.859 |
| May 14, 2024 | 7.412 |
| May 13, 2024 | 7.412 |
| May 10, 2024 | 7.086 |
| May 09, 2024 | 7.086 |
| May 08, 2024 | 7.086 |
| May 07, 2024 | 7.086 |
| May 06, 2024 | 7.086 |
| May 03, 2024 | 7.086 |
| May 02, 2024 | 7.086 |
| May 01, 2024 | 7.086 |
| April 30, 2024 | 7.086 |
| April 29, 2024 | 7.086 |
| April 26, 2024 | 7.086 |
| April 25, 2024 | 7.100 |
| April 24, 2024 | 7.766 |
| April 23, 2024 | 8.369 |
| April 22, 2024 | 7.100 |
| April 19, 2024 | 7.086 |
| April 18, 2024 | 7.086 |
| April 17, 2024 | 7.086 |
| April 16, 2024 | 7.086 |
| April 15, 2024 | 8.362 |
| Date | Value |
|---|---|
| April 12, 2024 | 8.362 |
| April 11, 2024 | 8.362 |
| April 10, 2024 | 7.129 |
| April 09, 2024 | 7.129 |
| April 08, 2024 | 7.129 |
| April 05, 2024 | 7.129 |
| April 04, 2024 | 7.129 |
| April 03, 2024 | 7.129 |
| April 02, 2024 | 7.129 |
| April 01, 2024 | 7.129 |
| March 31, 2024 | |
| March 28, 2024 | 7.027 |
| March 27, 2024 | 7.488 |
| March 26, 2024 | 7.488 |
| March 25, 2024 | 7.488 |
| March 22, 2024 | 7.907 |
| March 21, 2024 | 8.186 |
| March 20, 2024 | 8.577 |
| March 19, 2024 | 7.893 |
| March 18, 2024 | 7.893 |
| March 15, 2024 | 7.390 |
| March 14, 2024 | 8.176 |
| March 13, 2024 | 8.176 |
| March 12, 2024 | 8.176 |
| March 11, 2024 | 8.176 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
4.915
Minimum
Mar 30 2020
51.97
Maximum
Feb 27 2023
8.698
Average
8.414
Median
Mar 10 2021
Price to Book Value Benchmarks
| Hypera SA | 1.586 |
| CEL-SCI Corp | 4.808 |
| AIM ImmunoTech Inc | 2.107 |
| IGC Pharma Inc | 3.942 |
| NovaBay Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| PE Ratio | 38.84 |
| PS Ratio | 1.161 |
| PEG Ratio | 16.43 |
| Price | 4.90 |
| Earnings Yield | 2.57% |
| Market Cap | 8.404B |
| PEGY Ratio | 4.699 |
| Operating PE Ratio | 19.99 |
| Normalized PE Ratio | 45.72 |